Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
Kovesdy C , Schmedt N, Folkerts K, et al.
BMC Med. 2022;20(1):2
Leggi
Kovesdy C , Schmedt N, Folkerts K, et al.
BMC Med. 2022;20(1):2
Leggi
Lithovius R, Antikainen AA, Mutter S, et al.
Diabetes Care. 2022;dc210974
Leggi
Magliano DJ, Chen L, Carstensen B, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(21):00327-2
Leggi
Kolkailah AA, Wiviott SD, Raz I, et al.
Diabetes Care. 2022;dc211668
Leggi
Ata A, Jalilova A, Kırkgöz T, et al.
Clin Pediatr Endocrinol. 2022;31(1):33-37.
Leggi
Chao AM, Wadden TA, Clark JM, et al.
Diabetes Care. 2022;45(1):74-82.
Leggi
Gothong C, Singh LG, Satyarengga M, Spanakis EK.
Curr Opin Endocrinol Diabetes Obes. 2022;29(1):1-9.
Leggi
Singer ME, Dorrance KA, Oxenreiter MM, et al.
Prev Med Rep. 2022;25:101636
Leggi
Herder C, Roden M
Diabetologia. Pub. online 4 Jan 2022.
Leggi
Ho KL, Karwi QG, Lopaschuk GD, et al.
Diabetologia. Pub. online 7 Jan 2022.
Leggi